92471 ⎘
Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
TWO-DIMENSIONAL COVALENT ORGANIC FRAMEWORKS FOR HARVESTING MECHANICAL ENERGY
#2COMPOUNDS
#3COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER
#4COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER
#5INDANE-, INDENE-, AZAINDANE-, AND AZAINDENE-AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS
#6ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME
#7METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND
#8Strongly-polarized molecule, and single molecule field effect transistor prepared therefrom
#9COMPOSITIONS AND METHODS OF REGULATING CANCER RELATED DISORDERS AND DISEASES
#10Synergistic compositions
#11Adenylyl cyclase inhibitors for neuropathic and inflammatory pain
#12PROCESS FOR PREPARATION OF CINACALCET INTERMEDIATE AND CINACALCET HYDROCHLORIDE
#13Method of inhibiting apolipoprotein-E expression while increasing expression of at least one of LDL-receptor protein or AbcA1 protein comprising administering a small compound
#14Synergistic compositions
#15Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition
#16NEW INDICATION OF CINACALCET HCL PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#17Bacterial topoisomerase inhibitors and use thereof
#18PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#19Polyamine transport selective therapeutic agents with enhanced stability
#20Adenylyl cyclase inhibitors for neuropathic and inflammatory pain
#21Substituted naphthalene compounds as calcium sensing receptor modulators
#22Process for preparing cinacalcet and pharmaceutically acceptable salts thereof
#23Polyamine transporter selective compounds as anti-cancer agents
#24Synergistic compositions
#25Pesticidal compositions and processes related thereto
#26Pesticidal compositions and processes related thereto
#27Inhibiting neurotransmitter reuptake
#28Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#29Process for preparing cinacalcet and pharmaceutically acceptable salts thereof
#30Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#31Polyamine transport selective therapeutic agents with enhanced stability
#32Oligomer-calcimimetic conjugates and related compunds
#33Process for preparing Cinacalcet hydrochloride
#34Pesticidal compositions and processes related thereto
#35Pesticidal compositions and processes related thereto
#36Method for the preparation of cinacalcet and intermediates and impurities thereof
#37Polyamine transporter selective compounds as anti cancer agents
#38CALCIUM RECEPTOR-ACTIVE MOLECULES
#39Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives
#40Inhibiting neurotransmitter reuptake
#41Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#42Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#43Processes for the preparation of cinacalcet
#44Process for preparing cinacalcet
#45Oligomer-calcimimetic conjugates and related compounds
#46Process for the preparation of cinacalcet and salts thereof, and intermediates for use in the process
#47Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#48Method for the preparation of cinacalcet and intermediates and impurities thereof
#49HIGHLY PURE CINACALCET OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#50PROCESS FOR PREPARING CINACALCET HYDROCHLORIDE
#51PROCESSES FOR PREPARING CINACALCET HYDROCHLORIDE AND POLYMORPHIC FORMS THEREOF
#52Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives
#53Methods of synthesizing cinacalcet and salts thereof
#54Process for preparing Cinacalcet
#55Process For Controlling The Particle Size of A [3-(Trifluoromethyl)Phenyl]-1-Aminopropane Derivative
#56Surfactant Compositions and Synthesis
#57UNSATURATED CINACALCET SALTS AND PROCESSES FOR PREPARING CINACALCET HYDROCHLORIDE
#58PROCESS FOR PREPARING CINACALCET AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#59Surfactant-enabled transition metal-catalyzed chemistry
#60PROCESS FOR THE PREPARATION OF CINACALCET AND INTERMEDIATES THEREOF
#61Process for the synthesis of cinacalcet hydrochloride
#62CATIONIC TRANSITION METAL CATALYSTS
#63Methods of preparing secondary carbinamine compounds with boronic acids
#64Treatment of Neurodegenerative Diseases Using Indatraline Analogs
#65Inhibiting neurotransmitter reuptake
#66SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#67TRIFLUOROMETHYLPHENYL MODULATORS OF CALCIUM-SENSING RECEPTOR
#68PURIFICATION PROCESS
#69PROCESS FOR CONTROLLING THE PARTICLE SIZE OF A 3-(TRIFLUOROMETHYL)PHENYL]-1-AMINOPROPANE DERIVATIVE
#70AMORPHOUS FORM OF CINACALCET
#71Purification process
#72CRYSTALLINE FORM OF CINACALCET
#73Calcium receptor active compounds
#74Indene derivatives, their preparation and use as medicaments
#75METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF
#76Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof
#77Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#78PROCESS FOR THE PREPARATION OF CINACALCET
#79Melanocortin-4 receptor binding compounds and methods of use thereof
#80PREPARATION AND UTILITY OF SUBSTITUTED ALLYLAMINES
#81Process for preparing Cinacalcet
#82Amine Salts Of (-)-2-((2-(4-Hydroxyphenyl)Ethyl)Thio)-3-(4-(2-(4-((Methylsulfonyl)Oxy)Phenoxy)Ethyl)Phenyl) Propanoic Acid
#83Polyamine compounds
#84Process for the preparation of cinacalcet base
#85Process for the preparation of cinacalcet base
#86Process for the synthesis of terbinafine and derivatives thereof
#87Methods and compositions for making and using polymorphs of cinacalcet
#88Tetralone-based monoamine reuptake inhibitors
#89Crystal forms of Cinacalcet HCI and processes for their preparation
#90Calcium receptor modulating agents
#91Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
#92Processes for preparing cinacalcet hydrochloride crystal Form I
#93Malic acid addition salts of terbinafine
#94Purification of cinacalcet
#95Amorphous cinacalcet hydrochloride and preparation thereof
#96Process for preparing Cinacalcet hydrochloride
#97Process for the preparation of aromatic amines
#98Calcium receptor-active molecules
#99Immunomodulation with novel pharmaceutical compositions
#100Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
#101Purification process
#102Process for preparing terbinafine by using platinum as catalyst
#103Synthesis of alpha fluoroalkyl amines
#104Process for the preparation of terbinafine and salts thereof
#105High-selective production method of di(aminomethyl)-substituted aromatic compound
#106Purification process
#107Calcium receptor modulating agents
#108Polyamine compounds for treating chemokine receptor mediated diseases